Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Felodipine in ventricular dysfunction.

A C Tweddel, I Hutton

    European Heart Journal
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Felodipine effectively improved cardiac function in patients with chronic heart failure by acting as an arteriolar vasodilator. This medication increased cardiac output and coronary blood flow without raising myocardial oxygen demand, suggesting its potential in managing heart failure.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An alternative water transport system in land plants.

    Proceedings. Biological sciences·2018
    Same author

    Introduction of a Simple Second Tier Screening Test for C5 Isobars in Dried Blood Spots: Reducing the False Positive Rate for Isovaleric Acidaemia in Expanded Newborn Screening.

    JIMD reports·2017
    Same author

    Ecological speciation in sympatric palms: 2. Pre- and post-zygotic isolation.

    Journal of evolutionary biology·2016
    Same author

    Ecological speciation in sympatric palms: 1. Gene expression, selection and pleiotropy.

    Journal of evolutionary biology·2016
    Same author

    A comparative analysis of the mechanisms underlying speciation on Lord Howe Island.

    Journal of evolutionary biology·2013
    Same author

    Acetylator phenotype and the clinical pharmacology of slow-release procainamide.

    British journal of clinical pharmacology·2012
    Same journal

    The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

    European heart journal·2026
    Same journal

    Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

    European heart journal·2026
    Same journal

    Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

    European heart journal·2026
    Same journal

    Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

    European heart journal·2026
    Same journal

    Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

    European heart journal·2026
    Same journal

    Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

    European heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology
    • Internal Medicine

    Background:

    • Chronic cardiac failure secondary to coronary heart disease presents significant hemodynamic challenges.
    • Effective management requires interventions that improve cardiac output and myocardial perfusion.
    • Arteriolar vasodilators are a potential therapeutic class for heart failure management.

    Purpose of the Study:

    • To evaluate the systemic and coronary hemodynamic effects of felodipine in patients with chronic cardiac failure.
    • To assess felodipine's efficacy at rest and during stress (atrial pacing).

    Main Methods:

    • Fourteen patients with chronic cardiac failure due to coronary heart disease were studied.
    • Hemodynamic parameters were measured at rest and during stress-induced atrial pacing.

    Related Experiment Videos

  • Systemic and coronary blood flow, cardiac index, and stroke volume were assessed.

    • Main Results:

    • Felodipine significantly increased cardiac index (2.6 to 3.5 L/min/m²) and stroke volume (35.3 to 41.4 mL/beat/m²).
    • Coronary venous flow increased significantly (126 to 168 mL/min) without a corresponding rise in myocardial oxygen consumption.
    • Hemodynamic improvements were maintained during atrial pacing-induced myocardial stress.

    Conclusions:

    • Felodipine acts as an effective arteriolar vasodilator in patients with chronic cardiac failure.
    • It improves cardiac output and coronary blood flow while preserving myocardial oxygen balance.
    • Felodipine shows promise as a therapeutic agent for managing congestive cardiac failure.